Increasing evidence has implicated gangliosides, sialic acid-containing cell surface glycosphingolipids, in the biological and clinical behavior of many types of human tumors. Gangliosides are overexpressed and actively shed by tumor cells, can bind to normal cells in the tumor microenvironment, and have a number of biological properties that could conceivably alter tumor-host interactions to influence the survival of the malignant cells that carry these molecules. One major area of investigation is the modulation of cell signaling by gangliosides. Published studies have demonstrated modulation of growth factor signaling through the epidermal growth factor (EGF), fibroblast growth factor (FGF), platelet-derived growth factor (PDGF), Trk family, and insulin receptors. Studies conducted over the past 10 y have demonstrated either inhibition or enhancement of signaling by gangliosides, depending on cell type, ganglioside species, and experimental conditions. Of particular concern are conflicting studies that demonstrate opposite effects of gangliosides on the same growth factor receptor. This chapter discusses a methodological approach to addressing this apparent conflict.
OverviewGanglioside molecules consist of a sialic acid-containing carbohydrate portion and a hydrophobic lipid backbone (ceramide) embedded in the outer leaflet of the cell membrane (Ledeen and Yu, 1982). Individual carbohydrate species can be classified according to ganglioside biosynthetic pathways. Their biosynthesis, in a sequential order of glycosylations, occurs by two main pathways, designated "a" (GM2,GM1a,GD1a) and "b" (GD3,GD2,GD1b, GT1b, GQ1b), from a common precursor (GM3) derived from lactosylceramide (van Echten and Sandhoff, 1993) (Fig. 1). Each ganglioside is structurally more complex than its precursor molecule, and the stepwise addition of monosaccharide or sialic acid residues by specific membrane-bound glycosyltransferases in the Golgi apparatus is catalyzed by the same glycosyltransferases in both pathways. Gangliosides represent a diverse group of molecules, and marked structural differences in carbohydrate and ceramide structures distinguish the ganglioside complement of many tumors from that of normal tissue (Hakomori, 1996). This structural heterogeneity has implications for immunological activity, as evidenced, for example, by studies demonstrating differential immunosuppressive effects of ceramide subspecies of tumor gangliosides (Ladisch et al., 1994). Furthermore, gangliosides are overexpressed by tumor cells and shed into the tumor microenvironment. Tumor gangliosides can both influence the behavior of the tumor cells that produce them and can alter biological functions of target cells to which shed gangliosides bind.Gangliosides, which exist in glycosphingolipid-enriched domains (Hakomori et al., 1998), have several important biological properties, including potent immunosuppressive activity (Bergelson et al., 1989;Grayson and Ladisch, 1992;Ladisch et al., 1983;Lu and Sharom, 1996), proangiogenic activity (A...